Header Logo

Connection

VENEE TUBMAN to Female

Back to Details
This is a "connection" page, showing publications VENEE TUBMAN has written about Female.
VENEE TUBMAN
Connection Strength
0.300
Female
  1. Newborn screening results for sickle cell disease from the ASH Consortium on Newborn Screening in Africa (CONSA). Blood Adv. 2026 05 12; 10(9):3200-3206.
    View in: PubMed
    Score: 0.036
  2. Concomitant sickle cell disease and systemic lupus erythematosus: A single-center case series. Pediatr Blood Cancer. 2024 Oct; 71(10):e31194.
    View in: PubMed
    Score: 0.032
  3. Unswitched memory B cell deficiency in children with sickle cell disease and response to pneumococcal polysaccharide vaccine. Am J Hematol. 2024 06; 99(6):1084-1094.
    View in: PubMed
    Score: 0.032
  4. Indications for transfusion in the management of sickle cell disease. Hematology Am Soc Hematol Educ Program. 2021 12 10; 2021(1):696-703.
    View in: PubMed
    Score: 0.027
  5. Mother knows best: The caregiver's perspective on clinical trials for sickle cell disease highlights the challenges of providing care in Africa. Pediatr Blood Cancer. 2020 02; 67(2):e28054.
    View in: PubMed
    Score: 0.023
  6. Clinical and laboratory outcomes following total or partial splenectomy in patients with hereditary spherocytosis. Pediatr Hematol Oncol. 2019 Sep; 36(6):382-389.
    View in: PubMed
    Score: 0.023
  7. Acute lymphoblastic leukemia in a patient with MonoMAC syndrome/GATA2 haploinsufficiency. Pediatr Blood Cancer. 2016 10; 63(10):1844-7.
    View in: PubMed
    Score: 0.018
  8. Newborn Screening for Sickle Cell Disease in Liberia: A Pilot Study. Pediatr Blood Cancer. 2016 Apr; 63(4):671-6.
    View in: PubMed
    Score: 0.018
  9. Sickle solubility test to screen for sickle cell trait: what's the harm? Hematology Am Soc Hematol Educ Program. 2015; 2015:433-5.
    View in: PubMed
    Score: 0.017
  10. Building partnerships to target sickle cell anemia in Africa. Am J Hematol. 2013 Dec; 88(12):983.
    View in: PubMed
    Score: 0.015
  11. Sickle cell disease caused by Hb S/Qu?bec-CHORI: treatment with hydroxyurea and response. Pediatr Blood Cancer. 2007 Aug; 49(2):207-10.
    View in: PubMed
    Score: 0.010
  12. Acquired immune cytopenias post-cardiac transplantation respond to rituximab. Pediatr Blood Cancer. 2007 Mar; 48(3):339-44.
    View in: PubMed
    Score: 0.010
  13. X-linked gray platelet syndrome due to a GATA1 Arg216Gln mutation. Blood. 2007 Apr 15; 109(8):3297-9.
    View in: PubMed
    Score: 0.010
  14. Engaging Parents of Children With Sickle Cell Disease in Shared Decision-Making for Hydroxyurea: The ENGAGE-HU Study. Pediatr Blood Cancer. 2025 May; 72(5):e31639.
    View in: PubMed
    Score: 0.008
  15. Progressive Thrombocytopenia, Splenomegaly, and Abnormal Tone in an Infant With Growth Faltering. Pediatrics. 2024 Jul 01; 154(1).
    View in: PubMed
    Score: 0.008
  16. Unique Hemoglobinopathy Pattern Following Treatment with Voxelotor. Ann Clin Lab Sci. 2023 Jul; 53(4):647-652.
    View in: PubMed
    Score: 0.007
  17. A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease. N Engl J Med. 2019 08 08; 381(6):509-519.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.